FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   HOOPER ANTHONY C 2. Date of Event Requiring Statement (Month/Day/Year) 05/24/2007 3. Issuer Name and Ticker or Trading Symbol BRISTOL MYERS SQUIBB CO [(BMY)] (Last) (First) (Middle) BRISTOL-MYERS SQUIBB COMPANY, RT. 206 & PROVINCELINE ROAD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President US Pharmaceuticals 5. If Amendment, Date Original Filed(Month/Day/Year) 06/01/2007 (Street) PRINCETON, NJ 08540 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock, $0.10 par value 110,088 (1) D   Common Stock, $0.10 par value (2) 2,784.97 I By BMY Savings & Investment Program Common Stock, $0.10 par value 3,675 I By Spouse

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Executive Option (right to buy)	01/04/2000(3)	01/03/2009	Common Stock, $0.10 par value	30,813	$ 62.95	D	Â
Executive Option (right to buy)	03/06/2002(4)	03/05/2011	Common Stock, $0.10 par value	36,150	$ 59.78	D	Â
Executive Option (right to buy)	  (5)	02/28/2015	Common Stock, $0.10 par value	55,833	$ 25.45	D	Â
Executive Option (right to buy)	  (6)	03/06/2016	Common Stock, $0.10 par value	78,750	$ 22.73	D	Â
Executive Option (right to buy)	  (7)	11/30/2016	Common Stock, $0.10 par value	200,000	$ 24.74	D	Â
Executive Option (right to buy)	  (8)	03/05/2017	Common Stock, $0.10 par value	104,616	$ 27.01	D	Â
Option (right to buy)	03/03/1999(3)	03/02/2008	Common Stock, $0.10 par value	25,660	$ 48.45	D	Â
Option (right to buy)	01/03/2001(3)	01/02/2010	Common Stock, $0.10 par value	2,524	$ 61.09	D	Â
Option (right to buy)	03/07/2001(3)	03/06/2010	Common Stock, $0.10 par value	33,127	$ 42.64	D	Â
Option (right to buy)	03/05/2003(3)	03/04/2012	Common Stock, $0.10 par value	40,000	$ 48.08	D	Â
Option (right to buy)	06/04/2005(3)	06/03/2007	Common Stock, $0.10 par value	30,000	$ 28.9	D	Â
Option (right to buy)	03/04/2004(3)	03/03/2013	Common Stock, $0.10 par value	68,000	$ 23.14	D	Â
Option (right to buy)	  (9)	03/01/2014	Common Stock, $0.10 par value	63,333	$ 28.11	D	Â
Restricted Stock Units	  (10)	  (10)	Common Stock, $0.10 par value	26,151	$ (11)	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
HOOPER ANTHONY C BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON, NJ 08540	Â	Â	  President US Pharmaceuticals	Â

Signatures

By: /s/ Sonia Vora, Attorney-in-Fact		08/02/2007
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This Form 3 is being amended to correct the number of shares directly held. The total includes 83,578 shares of unvested restricted stock.
(2)	Based on a plan statement as of the end of the most recent fiscal quarter.
(3)	Currently Exercisable.
(4)	18,075 shares are currently exercisable. The remaining 18,075 shares are exercisable on the earlier to occur of (i) the closing share price achieving a price threshold and remaining at that threshold for a given number of days or (ii) March 6, 2009.
(5)	27,916 shares are currently exercisable. An additional 13,958 shares will become exercisable on each of March 1, 2008 and March 1, 2009.
(6)	19,687 shares are currently exercisable. The remaining shares will vest 25% on each of March 7, 2008, March 7, 2009 and March 7, 2010.
(7)	One-third of the options will become exercisable on each of December 1, 2009, December 1, 2010 and December 1, 2011.
(8)	Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. 25% of the shares vest annually, on a cumulative basis, on March 6, 2008, March 6, 2009, March 6, 2010 and Mach 6, 2011.
(9)	47,499 shares are currently exercisable and the remaining 15,834 shares will beome exercisable on March 2, 2008.
(10)	One-third of the restricted stock units will vest on each of March 6, 2010, March 6, 2011 and March 6, 2012 and will be converted into shares of common stock.
(11)	Each restricted stock unit converts into one share of common stock upon vesting.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.